Rayzebio Inc (RYZB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RYZB | AMGN | VRTX | REGN | BMY |
| Company | Rayzebio Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 62.49 | 269.00 | 395.72 | 710.20 | 56.22 |
| High | 62.50 | 269.61 | 401.31 | 717.61 | 57.33 |
| Low | 62.48 | 262.21 | 386.49 | 700.83 | 56.08 |
| Last | 62.49 | 263.38 | 397.27 | 701.85 | 57.33 |
| Change | +0.01 | +2.19 | +0.63 | -6.40 | +1.03 |
| % Change | +0.02% | +0.84% | +0.16% | -0.90% | +1.83% |
| Volume | 282,700 | 13,687,900 | 6,203,100 | 1,889,900 | 48,212,000 |
| 20-Day Average Volume | 318,060 | 5,160,835 | 1,820,960 | 920,920 | 11,813,050 |
| Previous Close | 62.48 | 261.19 | 396.64 | 708.25 | 56.30 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 62.28 | 275.02 | 456.96 | 747.95 | 57.98 |
| 20-Day Raw Stochastic | 95.83% | 22.90% | 19.69% | 8.20% | 40.60% |
| 20-Day Relative Strength | 86.10% | 32.27% | 29.29% | 27.71% | 52.59% |
| Weighted Alpha | N/A | -14.54 | -11.23 | -30.09 | +17.93 |
| Today's Opinion | N/A | 88% Sell | 72% Sell | 100% Sell | 80% Buy |
| Previous Opinion | N/A | 88% Sell | 56% Sell | 100% Sell | 80% Buy |
| Last Month's Opinion | N/A | 40% Sell | 8% Sell | 88% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.13% since 02/15/24 | -2.68% since 12/13/24 | -14.33% since 12/13/24 | -4.03% since 12/13/24 | +2.78% since 12/13/24 |
| Low | 62.42 on 02/16/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 693.00 on 12/19/24 | 55.68 on 12/16/24 |
| High | 62.51 on 02/22/24 | 272.69 on 12/16/24 | 474.18 on 12/17/24 | 745.00 on 12/18/24 | 58.54 on 12/18/24 |
| 1-Month | |||||
| %Chg | +0.87% since 01/23/24 | -8.51% since 11/20/24 | -11.96% since 11/20/24 | -5.58% since 11/20/24 | -0.95% since 11/20/24 |
| Low | 61.86 on 01/24/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 693.00 on 12/19/24 | 55.04 on 12/13/24 |
| High | 62.51 on 02/22/24 | 297.32 on 11/25/24 | 476.46 on 12/10/24 | 800.99 on 12/09/24 | 60.68 on 11/25/24 |
| 3-Month | |||||
| %Chg | +167.05% since 11/22/23 | -21.93% since 09/20/24 | -14.55% since 09/20/24 | -38.70% since 09/20/24 | +16.03% since 09/20/24 |
| Low | 22.14 on 11/27/23 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 693.00 on 12/19/24 | 49.11 on 09/25/24 |
| High | 62.51 on 02/22/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 1,154.56 on 09/23/24 | 61.08 on 11/11/24 |
| 6-Month | |||||
| %Chg | N/A since 09/15/23 | -15.01% since 06/20/24 | -15.72% since 06/20/24 | -32.80% since 06/20/24 | +39.69% since 06/20/24 |
| Low | 17.95 on 09/26/23 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 693.00 on 12/19/24 | 39.35 on 07/05/24 |
| High | 62.51 on 02/22/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 1,211.20 on 08/27/24 | 61.08 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,744,400 | 141,575,456 | 102,308,544 | 77,126,288 | 116,275,392 |
| Shares Outstanding, K | 59,920 | 537,533 | 257,529 | 109,890 | 2,028,177 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -68,600,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 2,771,900,000 | 3,720,700,000 | 11,892,000,000 |
| Last Quarter Net Income | -18,190,000 | 2,830,000,000 | 1,045,400,000 | 1,340,600,000 | 1,211,000,000 |
| 60-Month Beta | N/A | 0.55 | 0.36 | 0.08 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.26 on 11/13/23 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 12.46 on 10/31/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 03/04/24 | 02/04/25 | 02/03/25 | 02/07/25 | 02/06/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | N/A | 0.600 on 10/04/24 |
| Next Ex-Dividends Date | N/A | 02/14/25 | N/A | N/A | 01/03/25 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.59 | 0.00 | 17.72 | 48.12 |